REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/15/2026
Back to search
Official data from USPTO
NOVOGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
06/16/2026
Classification
Registered
Trademark type
Combined
Nice classes
10
Filing date
07/30/2020
Registration date
06/15/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/15/2021
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2003
First use in commerce
10/01/2014
Drawing code
3
Owner type
99
Owner location
Beijing, CN
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "NOVOGENE" with the letters "NOVO" in blue, and the letters "GENE" in green. The first letter "O" has a design of a green chromosome in the center. The color white represents background, shading, and/or transparent areas, and is not claimed as a feature of the mark.
Holders and representatives
Holders
Novogene Co., Ltd.
Representatives
Haoyi Chen ARCH & LAKE, LLP (HOUSTON OFFICE)
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Analyzers for bacterial identification for medical purposes; Apparatus for DNA and RNA testing for medical purposes; Cases fitted for medical instruments; Flow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for medicalclinicalmedical diagnostictherapeutic uses; Medical apparatus and instruments for use in surgery; Medical devices and apparatusmedical guidewires and parts and fittings therefor; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing blood sugar levelscancer cellsDNARNA and protein; Medical diagnostic apparatusanalytical apparatus for medical purposes and blood pressure measuring apparatus; Medical imaging apparatus for use in the field of proteins and peptides in drug development; Radiological apparatus for diagnostic and medical purposesmagnetic resonance imager
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/30/2021
PUBO
PUBLISHED FOR OPPOSITION
03/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/24/2020
GNRT
NON-FINAL ACTION E-MAILED
11/24/2020
CNRT
NON-FINAL ACTION WRITTEN
11/24/2020
DOCK
ASSIGNED TO EXAMINER
11/17/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2020
NWAP
NEW APPLICATION ENTERED
08/03/2020
Continuous trademark protection
Get notified about every new filing that threatens NOVOGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.